We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
-4.68%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$17.7B
AUM Growth
-$815M
(-4.4%)
Cap. Flow
+$169M
Cap. Flow
% of AUM
0.95%
Top 10 Holdings %
Top 10 Hldgs %
18.06%
Holding
3,210
New
168
Increased
1,509
Reduced
1,241
Closed
160
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust Enhanced Short Maturity ETF
FTSM
|
+$41.2M |
| 2 |
Schwab US Dividend Equity ETF
SCHD
|
+$30.6M |
| 3 |
iShares Ultra Short Duration Bond Active ETF
ICSH
|
+$29.6M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$28.3M |
| 5 |
Vanguard Ultra-Short Bond ETF
VUSB
|
+$26.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P Small-Cap 600 Value ETF
IJS
|
+$46M |
| 2 |
iShares S&P 500 Value ETF
IVE
|
+$45.2M |
| 3 |
iShares S&P Mid-Cap 400 Value ETF
IJJ
|
+$41.1M |
| 4 |
Invesco DB Commodity Index Tracking Fund
DBC
|
+$28.8M |
| 5 |
SPDR Gold Trust
GLD
|
+$28.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.86% |
| 2 | Financials | 4.76% |
| 3 | Consumer Discretionary | 4.5% |
| 4 | Healthcare | 4.18% |
| 5 | Consumer Staples | 2.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2476
Medpace
MEDP
$16.3B
| $262K | ﹤0.01% |
1,667
+119
| +8% | +$19K |
|
2477
TransDigm Group
TDG
$68.6B
| $262K | ﹤0.01% |
498
-12
| -2% | -$7.16K |
|
2478
Under Armour
UAA
$2.31B
| $262K | ﹤0.01% |
39,452
-9,117
| -19% | -$79.8K |
|
2479
Western Digital
WDC
$168B
| $262K | ﹤0.01% |
10,667
-580
| -5% | -$19.3K |
|
2480
Vanguard S&P Mid-Cap 400 Growth ETF
IVOG
$1.73B
| $261K | ﹤0.01% |
3,312
-6
| -0.2% | -$515 |
|
2481
Lennox International
LII
$14.5B
| $261K | ﹤0.01% |
1,170
+57
| +5% | +$13.6K |
|
2482
Acuity Brands
AYI
$10.8B
| $260K | ﹤0.01% |
1,654
+11
| +0.7% | +$1.86K |
|
2483
Beam Therapeutics
BEAM
$2.73B
| $260K | ﹤0.01% |
+5,461
| New | +$312K |
|
2484
InfraCap MLP ETF
AMZA
$477M
| $259K | ﹤0.01% |
9,097
-193
| -2% | -$5.8K |
|
2485
Principal Exchange-Traded Funds Principal US Small-Cap ETF
PSC
$2.33B
| $259K | ﹤0.01% |
7,036
-610
| -8% | -$24.5K |
|
2486
SolarEdge
SEDG
$1.98B
| $259K | ﹤0.01% |
1,120
-721
| -39% | -$213K |
|
2487
Euroseas
ESEA
$518M
| $258K | ﹤0.01% |
15,246
+2,434
| +19% | +$46K |
|
2488
Hartford Schroders Tax-Aware Bond ETF
HTAB
$291M
| $258K | ﹤0.01% |
+14,045
| New | +$272K |
|
2489
Mairs & Power Minnesota Municipal Bond ETF
MINN
$48.2M
| $258K | ﹤0.01% |
12,455
+1
| +0% | +$22 |
|
|
SA
2490
Seabridge Gold
SA
$3.44B
| $258K | ﹤0.01% |
21,775
-4,012
| -16% | -$50.8K |
|
2491
iShares China Large-Cap ETF
FXI
$4.15B
| $257K | ﹤0.01% |
9,946
-1,958
| -16% | -$58.6K |
|
2492
Intellia Therapeutics
NTLA
$1.67B
| $257K | ﹤0.01% |
4,591
+123
| +3% | +$7.63K |
|
2493
Nuveen ESG Mid-Cap Value ETF
NUMV
$459M
| $257K | ﹤0.01% |
9,060
+139
| +2% | +$4.46K |
|
2494
WhiteHorse Finance
WHF
$151M
| $257K | ﹤0.01% |
23,127
-1,367
| -6% | -$18.9K |
|
2495
Ameresco
AMRC
$1.47B
| $256K | ﹤0.01% |
3,854
-1,000
| -21% | -$61.4K |
|
2496
Independent Bank
INDB
$4.05B
| $256K | ﹤0.01% |
3,434
+602
| +21% | +$48.7K |
|
|
IMGN
2497
DELISTED
Immunogen Inc
IMGN
| $256K | ﹤0.01% |
53,463
-100
| -0.2% | -$527 |
|
2498
PIMCO Investment Grade Corporate Bond Index Exchange-Traded Fund
CORP
$1.58B
| $255K | ﹤0.01% |
2,800
-109
| -4% | -$10.5K |
|
|
ORAN
2499
DELISTED
Orange
ORAN
| $255K | ﹤0.01% |
28,357
+565
| +2% | +$5.77K |
|
2500
Cerence
CRNC
$390M
| $254K | ﹤0.01% |
16,144
-3,122
| -16% | -$70.1K |
|
Similar funds
LP
TI
Cambridge Investment Research Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Cambridge Investment Research Advisors held 3,210 positions worth $17.7B, down 4.4% from $18.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Cambridge Investment Research Advisors's Q3 2022 filing shows 168 new, 1,509 increased, 1,241 reduced and 160 closed positions. Its largest new stake was JPMorgan BetaBuilders US Equity ETF: 201,011 shares worth $12.9M. The largest sale was iShares S&P Small-Cap 600 Value ETF, an estimated $46M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, down from 9% a quarter earlier, followed by Financials and Consumer Discretionary.
- Cambridge Investment Research Advisors's largest Q3 2022 buy was JPMorgan BetaBuilders US Equity ETF: 201,011 shares worth $12.9M.
- Cambridge Investment Research Advisors added most to First Trust Enhanced Short Maturity ETF in Q3 2022, an estimated $41.2M increase.
- Cambridge Investment Research Advisors's biggest Q3 2022 reduction was iShares S&P Small-Cap 600 Value ETF, cutting an estimated $46M.
- Cambridge Investment Research Advisors fully exited Invesco DB Energy Fund in Q3 2022, selling an estimated $5.88M.
- Cambridge Investment Research Advisors's ten largest holdings make up 18% of its $17.7B portfolio in Q3 2022.
- Cambridge Investment Research Advisors opened 168 new positions and closed 160 in Q3 2022.
- Cambridge Investment Research Advisors's portfolio value fell 4.4% quarter-over-quarter to $17.7B.
Based on Cambridge Investment Research Advisors's 13F filing for Q3 2022, filed 17 Oct 2022.